Journal of Clinical Biochemistry and Nutrition

Papers
(The H4-Index of Journal of Clinical Biochemistry and Nutrition is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
TRIM62 knockdown by inhibiting the TLR4/NF-κB pathway and NLRP3 inflammasome attenuates cognitive impairment induced by diabetes in mice33
Sirtuin 3 ameliorates inflammatory bowel disease via inhibiting intestinal inflammation and oxidative stress29
A cross-sectional study on the relationship between nutrient/food intake and gut microbiota in frailty among older community residents: The Kyotango study23
The hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure17
The accumulation of copper in the brain of Down syndrome promotes oxidative stress: possible mechanism underlying cognitive impairment16
Quenching effect of cerium oxide nanoparticles on singlet oxygen: validation of the potential for reaction with multiple reactive oxygen species15
Characterization of the gut phageome of Japanese patients with ulcerative colitis under endoscopic remission14
Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients14
25-hydroxyvitamin D-1α-hydroxylase (CYP27B1) induces ectopic calcification12
Development of sandwich ELISAs for detecting glucagon-like peptide-1 secretion from intestinal L-cells and their application in STC-1 cells and mice12
The anti-inflammatory and protective role of interleukin-38 in inflammatory bowel disease12
Effect of folic acid supplementation on the change of plasma <i>S</i>-adenosylhomocysteine level in Chinese hypertensive patients: a randomized, double-blind, controlled clinical trial11
A nutritional intervention that promotes increased vegetable intake in Japanese with non-alcoholic fatty liver disease: a six-month trial11
Induction of <i>MYCN</i>-amplified neuro­blastoma differentiation through NMYC suppression using PPAR-γ antagonist11
0.049345970153809